ADAMTS7 is a member of the ADAMTS family of secreted zinc metalloproteases with characteristic protein domain composition, including at least 1 thrombospondin type I repeat. 6, 7 These proteins have highly homologous N-terminal protein domain structure and organization, but the C-terminal halves vary significantly, which is believed to confer substrate Background-Genome-wide association studies have established ADAMTS7 as a locus for coronary artery disease in humans. However, these studies fail to provide directionality for the association between ADAMTS7 and coronary artery disease. Previous reports have implicated ADAMTS7 in the regulation of vascular smooth muscle cell migration, but a role for and the direction of impact of this gene in atherogenesis have not been shown in relevant model systems. Methods and Results-We bred an Adamts7 whole-body knockout mouse onto both the Ldlr and Apoe knockout hyperlipidemic mouse models. Adamts7 /Apoe −/− mice displayed significant reductions in lesion formation in aortas and aortic roots compared with controls. Adamts7 knockout mice also showed reduced neointimal formation after femoral wire injury. Adamts7 expression was induced in response to injury and hyperlipidemia but was absent at later time points, and primary Adamts7 knockout vascular smooth muscle cells showed reduced migration in the setting of tumor necrosis factor-α stimulation. ADAMTS7 localized to cells positive for smooth muscle cell markers in human coronary artery disease lesions, and subcellular localization studies in cultured vascular smooth muscle cells placed ADAMTS7 at the cytoplasm and cell membrane, where it colocalized with markers of podosomes. Conclusions-These data represent the first in vivo experimental validation of the association of Adamts7 with atherogenesis, likely through modulation of vascular cell migration and matrix in atherosclerotic lesions. These results demonstrate that Adamts7 is proatherogenic, lending directionality to the original genetic association and supporting the concept that pharmacological inhibition of ADAMTS7 should be atheroprotective in humans, making it an attractive target for novel therapeutic interventions. 
C oronary artery disease (CAD) is a heritable disease and a leading cause of death and morbidity.
1 Recent large-scale genome-wide association studies (GWASs) have discovered and replicated >40 loci for CAD and myocardial infarction (MI). One of these loci on chromosome 15 contains the gene ADAMTS7 (a disintegrin and metalloproteinase with thrombospondin motifs- 7) , and was initially identified by our group through GWASs of angiographic CAD. 2 This finding has since been replicated multiple times for both CAD and MI in further meta-analyses, suggesting that ADAMTS7 is a novel regulator of atherogenesis in humans. [3] [4] [5] To date, however, the lack of human expression quantitative trait loci (eQTL) data in relevant tissues creates uncertainty about whether ADAMTS7 is the causal gene at the locus and prevents elucidation of the directionality between the actions of ADAMTS7 and disease pathogenesis. specificity. 8, 9 Previous research on ADAMTS7 has centered mainly on its role in bone and cartilage growth because cartilage oligomeric matrix protein (COMP) has been identified as a substrate.
10 ADAMTS7 can regulate endochondral bone formation through interactions with COMP, 11 but COMP is also expressed in vascular smooth muscle cells (VSMCs) and vasculature. 12 Additional studies with virus-mediated overexpression and knockdown in vivo and in vitro suggest that ADAMTS7 might modulate VSMC phenotype switching and migration. 13 Here, we present the first report of an Adamts7 knockout (KO; Adamts7 −/− ) mouse and demonstrate that Adamts7 deficiency in both the Ldlr −/− and Apoe −/− hyperlipidemic mouse models markedly attenuates the formation of atherosclerotic lesions; furthermore, wire-injury experiments in the Adamts7 −/− mouse show reduced neointima formation. We demonstrate that Adamts7 gene expression is induced transiently in the mouse vasculature in response to stress both in the wire injury model and in the atherosclerosis experiments, that tumor necrosis factor-a (TNFα) induces Adamts7 expression in primary VSMCs, and that VSMCs of Adamts7 −/− mice show reduced TNFα-induced migration. Finally, immunostaining in human diseased coronary arteries reveals colocalization of ADAMTS7 with cells positive for VSMC markers, and immunofluorescence in human aortic SMCs shows subcellular localization with leading edges of migrating VSMCs.
Methods
Expanded methods, including methods for generation of Adamts7 mouse strains, plasma lipid measurements, X-gal staining, vascular injury studies, primary aortic VSMC studies, aortic SMC immunofluorescence, and immunohistochemistry, are available in the onlineonly Data Supplement.
Atherosclerosis Studies

Adamts7
−/− mice were crossed onto the Ldlr and Apoe hyperlipidemic KO mouse backgrounds, and single-KO (Ldlr or Apoe alone) and double-KO (dKO) mice were obtained. Experimental dKO mice 8 to 12 weeks of age and control littermates were fed a Western diet (D12079Bi, Research Diets) for 16 weeks (Adamts7/Ldlr) or 10 weeks (Adamts7/Apoe), and then the mice were euthanized. Aortas were collected from the base of ascending aorta to the iliac bifurcation for en face lesion measurement, whereas aortic roots and brachiocephalic arteries (BCAs) were either X-gal stained as described above or paraffin embedded and used for lesion area quantification and immunohistochemistry.
For atherosclerosis lesion quantification, whole aortas were stained with Oil Red O as previously described, 14 and then the positively stained lesion area was measured. Data are reported as a percentage of entire aortic area. For aortic roots, lesion area was measured on hematoxylin and eosin-stained sections from paraffin-embedded hearts. We quantified lesion area in 5 serial sections (80 μm between sections). For selection of the 5 sections, we defined a zero point, which is the first section that captures all 3 leaflets of the aortic valve moving from the aortic arch toward the ventricles. Then, the 2 serial sections proximal (+1 and +2) and distal (−1 and −2) to the zero point were quantified. For each mouse, the data were represented as either the average lesion area (average area across the 5 points) or the area under the curve produced by integration of the total areas across all 5 sections (ie, the integrated area under the curve of root lesions).
Statistical Analysis
Data are presented as means, and all error bars represent standard errors. Statistical significance was tested with unpaired Student t tests, and a value of P≤0.05 was considered significant. For atherosclerosis studies, unpaired t tests were used to compare percent lesion area of aorta (en face) or actual lesion area (aortic roots) of Adamts7 −/− animals with control Adamts7 +/+ animals for each sex separately. For vascular injury studies, unpaired t tests were used to compare neointimal area, neointima-to-media ratio, and percent stenosis of Adamts7 −/− animals with control Adamts7 
Results
Characterization of Adamts7 Expression in WildType and KO Mice
We examined Adamts7 mRNA expression in a variety of murine tissues harvested from female C57BL/6 wild-type (WT) mice. Adamts7 expression varied greatly between tissues ( Figure 1A) , with the highest levels in heart, brain, lung, intestine, and adrenal gland. In contrast, low but detectable levels were observed in liver, spleen, kidney, brown fat, thyroid, and skeletal muscle. We commissioned the generation of an Adamts7 KO mouse (Adamts7 −/− ) in which the gene was ablated by use of a gene trap strategy with β-galactosidase gene (lacZ) insertion into intron 4 of the Adamts7 locus ( Figure 1B) . By design, splicing from exon 4 to the gene trap cassette results in a severely truncated protein containing only the signal peptide, the prodomain, and a small portion of the metalloprotease domain. The trapping cassette contains a LacZ reporter gene allowing X-gal staining as readout of active Adamts7 expression. Adamts7 gene KO was verified by real-time quantitative polymerase chain reaction with the use of 2 probe sets, 1 set that spans the exon 5 to 6 junction and 1 set that spans the exon 23 to 24 junction ( Figure 1C ).
Adamts7
−/− animals exhibited >95% reduction of the message in heart and lung ( Figure 1C ). X-gal staining of multiple tissues from Adamts7 −/− mice was consistent with the mRNA expression data from C57BL/6 mice and confirmed that the reporter was working. High levels of β-galactosidase activity were observed in the heart and pulmonary vasculature but not other tissues such as the liver and spleen ( Figure 1D ). Immunohistochemistry analysis for markers of cardiomyocytes (α-actinin), endothelial cells (platelet endothelial cell adhesion molecule-1), and epithelial cells (E-cadherin) localized the positive X-gal staining and thus Adamts7 expression to the myocardium of the heart and tunica media of 
Adamts7 KO Decreases Atherosclerosis in Hyperlipidemic Mouse Models
Atherosclerosis was quantified in Adamts7/Ldlr and Adamts7/Apoe dKO mice and control littermates. Mice were fed a Western diet for 16 weeks (Ldlr) or 10 weeks (Apoe). Aortas and aortic roots were harvested for lesion area quantification, whereas root and BCA sections were used for lesion characterization by immunohistochemistry. On a Western diet, no differences in plasma lipid levels were observed between experimental groups ( 
Adamts7 Deficiency Reduces the Neointimal Response to Vascular Injury and TNFα-Stimulated Migration of SMCs
Previous reports have implicated ADAMTS7 in SMC phenotype modulation in response to vascular injury. 15 To examine the role of Adamts7 in the response to vascular injury, we performed femoral artery wire injury and sham surgeries on Adamts7 −/− and WT littermates. Compared with WT littermates at 28 days after injury, Adamts7-null animals displayed a 64% reduction (P=0.05) in neointima formation ( Figure 5A and 5B), a 47% reduction in intima-to-media ratio ( Figure 5C ), and a 61% decrease in percent stenosis (P=0.003; Figure 5D ). Coincident with this reduction in neointima, expression of contractile markers within neointima, including smooth muscle-myosin heavy chain, smooth muscle α-actin, and smooth muscle-22α, was significantly greater in Adamts7 −/− mice after vascular injury compared with control mice ( Figure IV in the online-only Data Supplement). Thus, after acute mechanical vascular injury, ablation of the Adamts7 gene reduced neointimal formation and appeared to maintain VSMC phenotype.
In light of vascular injury findings, we tested whether primary aortic SMCs from Adamts7 −/− mice had reduced migration compared with those from control WT littermates. In initial studies, WT and KO VSMCs plated on collagen I, fibronectin, laminin, or uncoated plates displayed no differences in migratory ability. In prior studies of rat primary VSMCs, TNFα induced Adamts7 expression, 13 so we examined TNFα effects in WT VSMCs and found a similar upregulation (≈6-fold; P=0.0007) of Adamts7 ( Figure 5E ). Migration studies performed after 24 hours of TNFα treatment revealed a reduction in migration of TNFα-stimulated 
Adamts7 Expression Is Temporal and Transient During Vascular Injury and in Atherosclerosis
Our data suggest that Adamts7 modulates VSMC phenotype and migration during inflammatory stress and mechanical injury and that Adamts7 deficiency markedly reduces atherosclerotic lesions in hyperlipidemic mice. However, the atherosclerosis data did not yield clear differences in relative matrix or SMC composition of lesions at the time of sacrifice (after 16 and 10 weeks of Western diet feeding in Ldlr −/− and Apoe −/− models, respectively). Thus, we posited that murine Adamts7 might function predominantly in early lesion formation and that the imprint of Adamts7 deficiency is less visible on specific morphologies in more mature murine lesions. The β-galactosidase reporter in the exon-trapping cassette of the Adamts7 −/− mouse ( Figure 1B ) permits X-gal staining in harvested tissues, allowing identification of cells that actively transcribe the Adamts7 gene in animals carrying a KO allele. In light of the lack of working antibodies toward mouse Adamts7, we used this approach to examine the time course of vascular expression of Adamts7 in our vascular wire injury model and in atherosclerosis models.
First, we studied various time points after femoral wire injury (n=4 per time point). At day 1 after injury ( Figure 6A ) and day 28 after injury (time of harvest, data not shown), we saw no evidence of X-gal staining. However, at day 7 after injury ( Figure 6B ), blue staining indicative of β-galactosidase expression was apparent in injured vessels, localized predominantly to the media and adventitia, and this staining was almost completely absent at day 14 ( Figure 6C ). When considered in context of the reduction in lesions at day 28 after injury in Adamts7 −/− mice, this suggests that Adamts7 expression is induced early and transiently in response to the acute injury and affects remodeling at day 28 through its actions during the early pathophysiological response. Thus, the effects of Adamts7 deletion during injury may be confined to the early phase when VSMC migration plays a critical role. 16 In this context, we analyzed X-gal staining patterns in BCA and aortic roots from Adamts7/Apoe dKO mice fed a Western diet for varying lengths of time (n=3 per time point). BCAs from mice fed a Western diet for 1 week showed no atherosclerotic lesion formation and no positive X-gal staining ( Figure 6D ). At 4 weeks on a Western diet, however, a subset of Adamts7 −/− ; Apoe −/− mice had developed lesions in the BCA, and they displayed strong positive X-gal staining in the both media and lesion neointima ( Figure 6E ). Immunohistochemistry analysis of these lesions showed overlap with cells positive for smooth muscle α-actin but not smooth muscle-22 ( Figure VI in the online-only Data Supplement). In support of a transient induction of Adamts7 during the development of atherosclerosis, X-gal staining was not observed in BCA lesions at later time points (eg, 10 weeks), even though mature atherosclerotic plaques were present ( Figure 6F) . A similar pattern was observed in aortic roots of these mice; the only positive X-gal staining was observed in roots from mice fed a Western diet for 4 weeks (data not shown). X-gal staining of cultured primary VSMCs of Adamts7 −/− mice revealed modest positive staining under resting conditions, but this X-gal staining was markedly increased after treatment with TNFα ( Figure 6G ). These observations suggest that Adamts7 is induced transiently and expressed only during earlier stages of atherogenesis in mouse, likely via inflammatory (eg, TNFα) and hyperlipidemic triggers. This is consistent with its induction in the early phase of femoral artery injury and suggests that Adamts7 may be active at early phases of both mechanical vascular injury and Western diet/hyperlipidemia-induced vascular stress and atherosclerosis.
ADAMTS7 Is Expressed in Human Atherosclerosis and Localizes to the Migrating Edge of VSMCs
Our rodent data suggest a role for Adamts7 in promoting VSMC phenotypic transition and migration during arterial injury and hyperlipidemic atherogenic stress. To place these rodent observations in a human context, we obtained sections of diseased human coronary arteries (n=12) and performed immunohistochemical studies (Figure 7 and Figures VII and VIII in the online-only Data Supplement). ADAMTS7 consistently colocalized in the vascular media with the VSMC markers smooth muscle-22 and smooth muscle α-actin in all lesions examined ( Figure 7A-7D) . In fibrotic atherosclerotic lesions, ADAMTS7 also colocalized with smooth muscle-22-positive signal in the neointimal region of the lesion ( Figure 7B ). Interestingly, in more advanced lesions, smooth muscle-22 and smooth muscle α-actin consistently stained the fibrous cap, but limited ADAMTS7 staining was observed in those regions ( Figure 7B and 7C) . Conversely, in these advanced lesions, ADAMTS7 staining was observed in the lesion neointima in regions sometimes negative for VSMC markers ( Figure 7B and 7C) . In contrast, ADAMTS7 staining did not colocalize with the macrophage marker CD68 in any lesions examined (eg, Figure 7E ). These data show that ADAMTS7 is expressed in human arteries and lesions in medial VSMCs and suggest that ADAMTS7 stains neointimal cell populations, only a subset of which express classic VSMC markers.
To determine the subcellular localization of ADAMTS7 in human VSMCs, we also performed immunofluorescence in primary human aortic SMCs. Anti-ADAMTS7 staining demonstrated abundant protein expression in cytoplasmic granules and at the cell membrane ( Figure 8A ). ADAMTS7 was also found at the leading edge of cells and colocalized with cytoskeletal filaments and Na + /K + ATPase, a cell surface-expressed protein ( Figure 8B and 8C) . Furthermore, ADAMTS7 colocalized at the cell membrane with cortactin ( Figure 8D ), a marker of focal adhesions and podosomal complexes that orchestrates VSMC migration through vascular matrix.
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Discussion
Through GWASs, we identified ADAMTS7 as a novel locus for CAD in humans. 2 The association with this chromosome 15 locus has been reproduced in independent large GWAS meta-analyses.
3-5 The ADAMTS7 locus, however, has no relationship to traditional risk factors; the direction of its action in atherosclerosis is unknown; and the precise mechanisms of action in atherosclerosis remain to be determined. Indeed, whether ADAMTS7 is definitely the causal gene at the locus remains uncertain. Here, we present the first report of Adamts7 −/− mice and show that Adamts7 deficiency causes marked protection from Western diet-induced atherosclerosis in multiple hyperlipidemic mouse models, reduced neointimal formation after arterial injury, and decreased VSMC migration in vitro. These data not only strongly implicate ADAMTS7 as the causal gene at this human CAD locus but also provide evidence for a proatherogenic role of the gene in vivo and conversely an antiatherogenic effect of its genetic inhibition. Overall, our findings in 2 well-validated rodent model systems suggest that ADAMTS7 promotes atherosclerosis and that targeting its function could be a novel therapeutic strategy for atherosclerosis, CAD, and MI in humans.
Recent GWASs have identified >40 loci for CAD and MI. Unlike ADAMTS7, few novel loci have the combination of a clear candidate at the locus and plausible biology for the candidate gene. We discovered ADAMTS7 as a locus for coronary atherosclerosis using angiographic CAD as the outcome, and subsequent studies have shown that ADAMTS7 also relates to MI. However, its association is most robust for angiographic CAD, a marker of coronary atherosclerotic burden, suggesting that ADAMTS7 is likely to relate to clinical events through The family of ADAMTS proteases degrades extracellular matrix and has grown to 19 members. ADAMTS family members are associated with vascular diseases, including thrombotic thrombocytopenic purpura, 18 Weill-Marchesani syndrome, 19 and atherosclerosis. 20 Like all ADAMTS proteins, ADAMTS7 includes a signal peptide, a prodomain, a catalytic domain, a disintegrin-like domain, a central thrombospondin type I-like repeat, a cysteine-rich domain, a spacer region, and 7 C-terminal thrombospondin type I repeats. 15 Unlike other metalloproteinases, ADAMTSs demonstrate narrow substrate specificity as a result of their C-terminal exosites. ADAMTS7 has been implicated in bone development and in inflammatory arthritis through degradation of COMP, a pentameric glycoprotein involved in inherited human chondrodysplasias. 10 Previously published data suggest that the ADAMTS7-COMP interaction may extend to the vasculature. VSMC phenotypic switching and matrix remodeling play important roles in vascular disease and contribute to the development and progression of atherosclerosis. Studies in rats suggest that COMP may maintain VSMCs in a contractile phenotype. 21 Adenoviral overexpression of ADAMTS7 increased COMP cleavage and neointima in injured arteries, whereas overexpression of COMP blocked ADAMTS7 effects. 13 Whether acute effects using transient overexpression extend to vascular pathophysiology and atherosclerosis during germline modulation has not been studied.
Most domains in human and mouse Adamts7 are highly conserved, rendering the mouse as a useful model for actions in human disease. We obtained whole-body KO mice, bred them onto both the Ldlr −/− and Apoe −/− KO hyperlipidemic mouse models, and performed atherosclerosis studies in both males and females of each strain. Loss of Adamts7 clearly and significantly reduced atherosclerotic burden in the aortas and aortic roots of these mice in both sexes and both strains. Femoral artery wire injury is an established model in mice for studying VSMC phenotype transitions and matrix remodeling during vascular injuries of relevance to clinical vascular pathophysiologies, for example, restenosis during coronary angioplasty and stent implantation. At 28 days after femoral injury or sham surgery, Adamts7 −/− mice had reduced neointima formation and intima-to-media ratio compared with WT mice. Primary aortic VSMCs from Adamts7 −/− mice displayed decreased migration on collagen-and laminin-coated plates, but only in the setting of TNFα stimulation. TNFα, a proinflammatory cytokine, and, more broadly, activation of innate immune proinflammatory signals have been implicated in atherosclerosis in both rodent hyperlipidemic models 22 and human studies, 23 and in the modulation of VSMC migration. 24 It is plausible that ADAMTS7 plays a key role in mediating VSMC responses to inflammatory stresses in atherosclerosis and facilitates VSMC phenotype transition and localized matrix remodeling. We observed a lack of Adamts7 expression in mouse aortas under resting conditions. In combination with our data in mouse atherosclerosis and femoral injury, this suggests, at least in these mouse models, that induction of Adamts7 may be important in VSMC phenotype transition during injury response and development of atherosclerosis but not in murine vascular homeostasis. The lack of any vascular developmental defects in germline Adamts7 deletion also supports this concept. X-gal staining of mouse vasculature at various time points after femoral wire injury or Western diet feeding confirms that Adamts7 vascular expression is transient and temporal, peaking early after both mechanical and hyperlipidemic vascular insults. Stimulation of primary VSMCs with TNFα also dramatically increased positive X-gal staining of these cells, suggesting that TNFα (and other proinflammatory cytokines) may play a key role in Adamts7 induction in response to injury.
Understanding the relationship between CAD risk alleles in the ADAMTS7 genomic region and expression levels of ADAMTS7 in disease-relevant cells could facilitate translation of our rodent findings into human therapeutics. Interestingly, in available eQTL data sets with large sample sizes (eg, LCL eQTL from the Multiple Tissue Human Expression Resource [MuTHER] study; n=850), 25 the lead single-nucleotide polymorphisms from the PennCath (rs1994016), Coronary Artery Disease Genome-Wide Replication and Meta-Analysis (CARDIoGRAM; rs3825807), and Coronary Artery Disease Genetics Consortium (C4D; rs4380028) GWAS studies display a significant association with ADAMTS7 expression (eQTL: P=0.0011, P=0.00097, and P=0.0028, respectively), 25 matching the directionality and causality of our in vivo data; that is, the CAD risk alleles are associated with higher ADAMTS7 expression. However, there currently are no large eQTL or genomic allelic imbalance data that provide adequate power to determine eQTL directionality in the most pertinent human cells and vascular tissues (ie, coronary lesions, coronary or aortic SMCs) to more definitely support that ADAMTS7 functions to promotes human atherosclerosis and CAD. Work by our group and consortia such as GenotypeTissue Expression Project (GTEx) will soon produce data sets from a large-enough sample pool of human vasculature to address this question. Currently, however, our rodent studies provide the first data in established atherosclerosis models that suggest Adamts7 is proatherogenic in vivo. These rodent data are also in broad agreement with a recent report suggesting that a CAD-promoting coding variant in humans is associated with reduced ADAMTS7 protein secretion and function. 26 Our data strongly suggest that in mouse models of atherosclerosis and vascular injury, Adamts7 plays a key role in the regulation of VSMC phenotype switching and the development of atherosclerosis. However, how the transient and stress-dependent vascular expression pattern of Adamts7 in mouse relates to what occurs in human disease is uncertain. In an attempt to explore this question, we isolated human coronary arteries and performed immunohistochemistry for ADAMTS7 in diseased artery sections. In contrast to mouse aortas, ADAMTS7 expression was not apparently transient and identified in the media of a wide range of stages and types of human atherosclerosis. In further contrast to mouse, ADAMTS7 protein was expressed in advanced human lesions in both media and the neointima, predominantly, but not exclusively, colocalizing with cells expressing SMC markers. This may be relevant for clinical and therapeutic translation. Whereas in rodents it may be necessary to block Adamts7 function early in the disease process to produce an antiatherosclerotic effect (ongoing studies), the expression of ADAMTS7 in advanced atherosclerotic lesions and early lesions suggests that therapeutic inhibition of ADAMTS7, even in established and advanced human disease, might translate to clinical benefit. Such questions require additional rodent and human experiments and trials.
Finally, we examined ADAMTS7 protein expression in human aortic SMCs and found its immunofluorescent localization to both the cytoplasm and cell membrane, with specific colocalization to cytoskeletal filaments with markers of podosomes. Matrix metalloproteases are shuttled to the cell membrane to podosome-like structures in response to extracellular stimuli and mediate migration through cell-tissue matrixes. 17, 27 Interestingly, ADAMTS1, 4, and 5 also have previously been localized to podosome structures. 28 Our immunofluorescent staining and rodent models suggests that ADAMTS7 may perform a similar function in vascular remodeling.
Conclusions
ADAMTS7 is a genetic locus for CAD and MI in human, and our data are the first to show in vivo that ADAMTS7 is proatherosclerotic and may promote progression and complications of the disease by modulating VSMC phenotype. Because ADAMTS7 has a narrow substrate specificity, it has promise as a potentially safe drug target. Our findings provide support for the development of ADAMTS7 inhibitors in the prevention and treatment of human coronary atherosclerotic diseases.
CLINICAL PERSPECTIVE
Through genome-wide association studies, we recently identified the metalloproteinase ADAMTS7 as a locus for coronary artery disease. Other than low-density lipoprotein cholesterol-related genes, few of the >40 validated loci for coronary artery disease identified through genome-wide association studies have known mechanisms of action in atherosclerotic heart diseases. Indeed, for many loci, the gene(s) at the locus is (are) unknown or uncertain. ADAMTS7 is relatively unique as a genome-wide association study locus in having a single strong candidate gene at the locus, plausible biological mechanisms, and potential for therapeutic translation. Here, we present the first report of the Adamts7-deficient (Adamts7 −/− ) mouse, which, once crossed onto a hyperlipidemic background, displays reduced atherosclerotic lesion formation after prolonged feeding of a Western diet. We also show that Adamts7 expression is induced in response to both mechanical wire injury and hyperlipidemia and that primary smooth muscle cells from Adamts7 −/− mice display reduced migration when stimulated by tumor necrosis factor-α. Our findings are the first in vivo data to provide directionality to the genetic association between ADAMTS7 and coronary artery disease in humans. These data clearly demonstrate that ADAMTS7 is proatherogenic, likely through modulation of vascular smooth muscle cell phenotype in response to injury and inflammation. Importantly, these data provide early promise that inhibition of ADAMTS7, which is tractable given its narrow substrate specificity, might represent a novel mechanism for prevention and treatment of clinical cardiovascular diseases. Thus, it is one of the very few novel nonlipid findings from genome-wide association studies of coronary artery disease that have the potential to be a bona fide novel therapeutic target.
SUPPLEMENTAL MATERIAL Supplemental Methods:
Generation of Adamts7 mouse strains: Adamts7 -/-mice were generated by request at the Knockout Mouse Project (KOMP, University of California, Irvine). More information about the construction of these mice can be fond on the KOMP website 
